Search results

Filters

  • Journals
  • Authors
  • Keywords
  • Date
  • Type

Search results

Number of results: 449
items per page: 25 50 75
Sort by:
Download PDF Download RIS Download Bibtex

Abstract

Aim: The aim of this study was to assess long-term outcomes and complications associated with conservative and operative treatment of distal radius fractures and to determine if restoration of radio-graphic parameters influences functional outcomes.
Introduction: Distal radius fractures (DRFs) are common injuries associated with many complica-tions. Numerous studies suggest that operative treatment with anatomic reduction and restoration of radiographic parameters leads to better functional outcomes than nonsurgical treatment.
Materials and Methods: We enrolled 207 patients with isolated DRF (mean age 64 ± 17.9 years, women 150 (72.5%)) to our retrospective, single-center study (101 treated operatively, 106 treated non-operatively). There were no significant differences in sex, age, AO type fracture between study groups. After 3.9 ± 1.6 years (mean ± SD) clinical, functional and radiological assessment was conducted using Disabilities of the Arm, Shoulder and Hand (DASH), Patient Rated Wrist Evaluation (PRWE), 9-Hole Peg Test (9-HPT), grip and pinch strength tools.
Results: We found higher rates of malunion in nonoperative group (p <0.0001) and worse radiologic parameters such as volar tilt (p <0.0001), teardrop angle (p <0.0001) versus operative cohort. Nevertheless radiological parameters were not correlated with DASH and PRWE results. Moreover, patients aged 50 years and above treated operatively had similar functional outcomes (DASH, PRWE) to those treated nonoperatively.
Conclusions: Restoration of anatomic and thus radiologic parameters of radius may not be obligatory to achieve satisfactory functional outcome in patients with DRF aged 50 years or above. Patient is the most important ‘factor’ in determining appropriate and successful treatment method of distal radius fractures.
Go to article

Authors and Affiliations

Jakub Marchewka
1 2
Jakub Szczechowicz
1
Wojciech Marchewka
3
Edward Golec
1

  1. Department of Physiotherapy, University of Physical Education, Kraków, Poland
  2. Department of Orthopedics and Trauma Surgery, 5th Military Hospital, Kraków, Poland
  3. Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

The purpose of the research was to define the frequency prevalence of the incorporation of sphenoid sinuses’ septum / septa in the carotid canal of the adult population.
M a t e r i a l s and M e t h o d s: 296 computed tomography (CT) scans of the patients (147 females, 149 males), who did not present any pathology in the sphenoid sinuses, were evaluated in this retrospective analysis. Spiral CT scanner — Siemens Somatom Sensation 16 — was used to glean the medical images. Standard procedure applied in the option Siemens CARE Dose 4D. No contrast medium was administered. Multiplans reconstruction (MPR) tool was used in order to obtain frontal and sagittal planes from the transverse planes previously received.
R e s u l t s: Bilateral incorporation of the main septum (MS) in the carotid canal was not present in any of the patients, whereas unilateral incorporation was noticed in 21.96% of the patients (17.68% females, 26.17% males). On the right side it occurred in 11.82% of cases (10.88% females, 12.75% males), and on the left side in 10.14% of cases (6.8% females, 13.42% males). Bilateral incorporation of the additional septum (AS) was found in 8.45% of the patients (4.08% females, 12.75% males), whereas unilateral incorporation was noted in 28.37% of the patients. It was seen on the right side in 11.82% of cases (12.93% females, 10.74% males), and on the left side in 16.55% cases (15.65% females, 17.45% males). The most common variant was the incorporation of only one of the septa (either the MS or the AS) in the wall of the carotid canal unilaterally. Such situation took place in 30.07% of the patients (29.25% females, 30.87% males).
Incorporation of two septa on the same side was noticed in 4.39% of cases (4.08% females, 4.7% males), and incorporation of three septa in 0.34% of cases (0.7% males).
C o n c l u s i o n s: The anatomy of the paranasal sinuses is varied to a great extent, hence performing a CT scan is crucial before the scheduled surgery, as it may lessen the unforeseeable surgical complications, that may result from the high prevalence of variants in the sinuses.


Go to article

Bibliography

1. Jaworek-Troć J., Zarzecki M., Bonczar A., Kaythampillai L.N., Rutowicz B., Mazur M., Urbaniak J., Przybycień W., Piątek-Koziej K., Kuniewicz M., Lipski M., Kowalski W., Skrzat J., Loukas M., Walocha J.: Sphenoid bone and its sinus — anatomo-clinical review of the literature including application to FESS. Folia Med Crac. 2019; 59 (2): 45–59. doi: 10.24425/fmc.2019.128453.
2. Jaworek-Troć J., Zarzecki M., Mróz I., Troć P., Chrzan R., Zawiliński J., Walocha J., Urbanik A.: The total number of septa and antra in the sphenoid sinuses — evaluation before the FESS. Folia Med Crac. 2018; 58 (3): 67–81. doi: 10.24425/fmc.2018.125073.
3. Jaworek-Troć J., Iwanaga J., Chrzan R., Zarzecki J.J., Żmuda P., Pękala A., Tomaszewska I.M., Tubbs R.S., Zarzecki M.P.: Anatomical variations of the main septum of the sphenoidal sinus and its importance during transsphenoidal approaches to the sella turcica. Translational Research in Anatomy. 2020 Nov; 21: 100079, https://doi.org/10.1016/j.tria.2020.100079.
4. Abdullah B.J., Arasaratnam A., Kumar G., Gopala K.: The sphenoid sinuses: computed tomographic assessment of septation, relationship to the internal carotid arteries and sidewall thickness in the Malaysian population. J HK Coll Radiol. 2001; 4: 185–188.
5. Eryilmaz A., Ozeri C., Bayiz U., Samim E., Gocmen H., Akmansu H., Safak M.A., Dursun E.: Functional endoscopic sinus surgery (FESS). Turk J Med Res. 1993; 11 (5): 221–223.
6. Haetinger R.G., Navarro J.A.C., Liberti E.A.: Basilar expansion of the human sphenoidal sinu: an integrated anatomical and computerized tomography study. Eur Radiol. 2006; 16: 2092–2099.
7. Kantarci M., Karasen R.M., Alper F., Onbas O., Okur A., Karaman A.: Remarkable anatomic variantions in paranasal sinus region and their clinical importance. European Journal of Radiology. 2004; 50: 296–302.
8. Kazkayasi M., Karadeniz Y., Arikan O.K.: Anatomic variations of the sphenoid sinus on computed tomography. Rhinology. 2005; 43: 109–114.
9. Keast A., Yelavich S., Dawes P., Lyons B.: Anatomical variations of the paranasal sinuses in Polynesian and New Zealand European computerized tomography scans. Otolaryngology-Head and Neck Surgery. 2008; 139: 216–221.
10. Mafee M.F., Chow J.M., Meyers R.: Functional endoscopic sinus surgery: anatomy, CT screening, indications and complications. AJR. 1993; 160: 735–744.
11. Mutlu C., Unlu H.H., Goktan C., Tarhan S., Egrilmez M.: Radiologic anatomy of the sphenoid sinus for intranasal surgery. Rhinology. 2001; 39: 128–132.
12. Perez-Pinas I., Sabate J., Carmona A., Catalina-Herrera C.J., Jimenez-Castellanos J.: Anatomical variations in the human paranasal sinus region studied by CT. J Anat. 2000; 197: 221–227.
13. Sareen D., Agarwail A.K., Kaul J.M., Sethi A.: Study of sphenoid sinus anatomy in relation to endoscopic surgery. Int. J Morphol. 2005; 23 (3): 261–266.
14. Terra E.R., Guedes F.R., Manzi F.R., Boscolo F.N.: Pneumatization of the sphenoid sinus. Dentomaxillofacial Radiology. 2006; 35: 47–49.
15. Becker D.G.: The minimally invasive, endoscopic approach to sinus surgery. Journal of Long-Term Effects of Medical Implants. 2003; 13 (3): 207–221.
16. Bogusławska R.: Badanie zatok przynosowych metoda tomografii komputerowej dla celów chirurgii endoskopowej. Warszawa 1995.
17. Krzeski A., Osuch-Wójcikiewicz E., Szwedowicz P., Tuszyńska A.: Chirurgia endoskopowa w leczeniu guzów jam nosa i zatok przynosowych. Mag ORL. 2004; 3 (3): 79–84.
18. Kapur E., Kapidzic A., Kulenovic A., Sarajlic L., Sahinovic A., Sahinovic M.: Septation oft he sphenoid sinus and ist clinical significance. International Journal of Collaborative Research on Internal Medicine & Public Health. 2012; 4 (10): 1793–1802.
19. Fernandez-Miranda J.C., Prevedello D.M., Madhok R., Morera V., Barges-Coll J., Reineman K., Snyderman C.H., Gardner P., Carrau R., Kassam A.B.: Sphenoid septations and their relationship with internal carotid arteries: anatomical and radiological study. Laryngoscope. 2009; 119: 1893–1896.
20. Sethi D.S., Stanley R.E., Pillay P.K.: Endoscopic anatomy of the sphenoid sinus and sella turcica. The Journal of Laryngology and Otology. 1995; 109: 951–955.
21. Lupascu M., Comsa Gh.I., Zainea V.: Anatomical variations of the sphenoid sinus — a study of 200 cases. ARS Medica Tomitana. 2014; 2 (77): 57–62.
22. Bademci G., Unal B.: Surgical importance of neurovascular relationships of paranasal sinus region. Turkish Neurosurgery. 2005; 15 (2): 93–96.
23. Elwany S., Elsaeid I., Thabet H.: Endoscopic anatomy of the sphenoid sinus. The Journal of Laryngology and Otology. 1999; 113: 122–126.
24. Anusha B., Baharudin A., Philip R., Harvinder S., Mohd Shaffie B., Ramiza R.R.: Anatomical variants of surgically important landmarks in the sphenoid sinus: a radiologic study in Southeast Asian patients. Surg Radiol Anat. 2015; 37: 1182–1190.
25. Hamid O., El Fiky L., Hassan O., Kotb A., El Fiky S.: Anatomic variations of the sphenoid sinus and their impact on trans-sphenoid pituitary surgery. Skull Base. 2008; 18 (1): 9–15.
26. Stokovic N., Trkulja V., Dumic-Cule I., Cukovic-Bagic I., Lauc T., Vukicevic S., Grgurevic L.: Sphenoid sinus types, dimensions and relationship with surrounding structures. Ann Anat. 2016; 203: 69–76.
27. Tan H.M., Chong V.F.H.: CT of the paranasal sinuses: normal anatomy, variations and pathology. CME Radiology. 2001; 2 (3): 120–125.
28. Jaworek-Troć J., Walocha J.A., Chrzan R., Żmuda P., Zarzecki J.J., Pękala A., Depukat P., Kucharska E., Lipski M., Curlej-Wądrzyk A., Zarzecki M.P.: Protrusion of the carotid canal into the sphenoid sinuses: evaluation before endonasal endoscopic sinus surgery. Folia Morph. 2020 (Ahead of print). doi: 10.5603/FM.a2020.0086.
29. Jaworek-Troć J., Walocha J.A., Loukas M., Tubbs R.S., Iwanaga J., Zawiliński J., Brzegowy K., Zarzecki J.J., Curlej-Wądrzyk A., Kucharska E., Burdan F., Janda P., Zarzecki M.P.: Extensive pneumatisation of the sphenoid bone — anatomical investigation of the recesses of the sphenoid sinuses and their clinical importance. Folia Morph. 2020 (Ahead of print). doi: 10.5603/FM.a2020.0120.
Go to article

Authors and Affiliations

Joanna Jaworek-Troć
1 2
Michał Zarzecki
1
Dariusz Lusina
1
Tomasz Gładysz
3
Paweł Depukat
1
Agata Mazurek
1
Wojciech Twardokęs
4
Anna Curlej- Wądrzyk
5
Joe Iwanaga
6
Ewa Walocha
7
Robert Chrzan
2
Andrzej Urbanik
2

  1. Department of Anatomy, Jagiellonian University Medical College, Kraków, Poland
  2. Department of Radiology, Jagiellonian University Medical College, Kraków, Poland
  3. Department of Dental Surgery, Institute of Dentistry, Jagiellonian University Medical College, Kraków, Poland
  4. Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, University of Technology in Katowice, Zabrze, Poland
  5. Department of Integrated Dentistry, Institute of Dentistry, Jagiellonian University Medical College, Kraków, Poland
  6. Department of Neurosurgery, Tulane University, New Orleans, USA
  7. Department of Clinical Nursing, Institute of Nursing and Obstetrics, Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

Background: pharmacists remain on the frontline of public health around the globe and their performance directly impacts patients’ safety. So far, to our knowledge, no European study has been dedicated to their heath-related quality of life (HQoL). Therefore, the primarily aim of our study was to evaluate HQoL of Polish pharmacists utilizing the SF-36 health survey with regard to anthropometric and lifestyle-related variables.
Methods: A total sample screened consisted of 1412 respondents, yet 765 pharmacists (mean age 40, 86.3% females) finally participated in the study. HQoL was assessed with the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36).
Results: The lowest median scores were noted for general health (GH, 50.0) and vitality (V, 60.0) domains. No gender differences regarding physical and mental summary scores were found. Significant difference of HQoL was found among the assessed age groups in several domains, especially physical functioning (PF) and GH (p <0.001) scores, and especially in the group of 51–60-year-old-respondents. Correlations were found between PF (r = –0.29, p <0.001), GH (r = –0.25, p <0.001) and age as well PF (r = –0.27, p <0.001), GH (r = –0.21, p <0.001) and BMI. Self-assessed dietary habits were correlated with PF (r = 0.22, p <0.001), mental health (r = 0.25, p <0.001), GH (r = 0.27, p <0.001) and V (r = 0.30, p <0.001) scores.
Conclusions: The analysis indicates that pharmacists tend to have similar mental and physical burden according to SF-36, with age, BMI and dietary habits as predominant factors influencing their HQoL. The study presents unique values for future comparative analyses related, for instance, to the influence of the ongoing pandemic on HQoL of health-care providers.
Go to article

Authors and Affiliations

Magdalena Kurnik-Łucka
1
Paweł Pasieka
1
Agnieszka Górecka-Mazur
1
Elżbieta Rząsa-Duran
2
Jakub Pękala
1
Krzysztof Gil
1

  1. Department of Pathophysiology, Jagiellonian University Medical College, Kraków, Poland
  2. Pharmacists’ Chamber of Lesser Poland, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

B a c k g r o u n d: The aim of this study was to determine the effect of sesquiterpene lactone parthenolide on the cytotoxic and pro-oxidative effects of etoposide in HL-60 cells.
M e t h o d s: Cytotoxic effects were determined by incubation of HL-60 cells with various concentrations of examined compounds and combinations thereof, which were then stained with propidium iodide and analyzed using a flow cytometer. To determine the role of oxidative stress in the action of the compounds, co-incubation with N-acetyl-l-cysteine (NAC) and parthenolide and/or etoposide was used and the level of reduced glutathione (GSH) was detected.
R e s u l t s: Parthenolide significantly enhanced the cytotoxic and pro-apoptotic effects of etoposide. However, in most cases of the combinations of parthenolide and etoposide, their effect was antagonistic, as confirmed by an analysis using the CalcuSyn program. The examined compounds significantly reduced the level of GSH in HL-60 cells. Combination of etoposide at a concentration of 1.2 μM and parthenolide also significantly reduced GSH level. However, in the case of a combination of etoposide at a concentration of 2.5 μM with parthenolide, a significant increase in the level of GSH was obtained compared to compounds acting alone. This last observation seems to confirm the antagonism between the compounds tested.
C o n c l u s i o n s: Parthenolide did not limit the cytotoxic effect of etoposide in HL-60 cells even in the case of antagonistic interaction. If parthenolide does increase GSH levels in combination with etoposide in the normal hematopoietic cells, it could protect them against the pro-oxidative effects of this anti-cancer drug.
Go to article

Bibliography

1. Bell J.A., Galaznik A., Huelin R., Stokes M., Guo Y., Fram R.J., Faller D.V.: Effectiveness and safety of therapeutic regimens for elderly patients with acute myeloid leukemia: a systematic literature review. Clin Lymphoma Myeloma Leuk. 2018; 18: e303–e314.
2. Hackl H., Astanina K., Wieser R.: Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia. J Hematol Oncol. 2017; 20: 51.
3. Foran J.M.: Do cytogenetics affect the post-remission strategy for older patients with AML in CR1? Best Pract Res Clin Haematol. 2017; 30: 306–311.
4. Yunos N.M., Beale P., Yu J.Q., Huq F.: Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cel lines. Anticancer Res. 2011; 31: 4283–4290.
5. Shah K., Mirza S., Desai U., Jain N., Rawal R.: Synergism of curcumin and cytarabine in the down regulation of multi-drug resistance genes in acute myeloid leukemia. Anticancer Agents Med Chem. 2016; 16: 128–135.
6. Banudevi S., Swaminathan S., Maheswari K.U.: Pleiotropic role of dietary phytochemicals in cancer: emerging perspectives for combinational therapy. Nutr Cancer. 2015; 67: 1021–1048.
7. Pei S., Minhajuddin M., D’Alessandro A., Nemkov T., Stevens B.M., Adane B., Khan N., Hagen F.K., Yadav V.K., De S., Ashton J.M., Hansen K.C., Gutman J.A., Pollyea D.A., Crooks P.A., Smith C., Jordan C.T.: Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells. J Biol Chem. 2016; 291: 21984–22000.
8. Guzman M.L., Rossi R.M., Karnischky L., Li X., Peterson D.R., Howard D.S., Jordan C.T.: The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood. 2005; 105: 4163–4169.
9. Papiez M.A., Baran J., Bukowska-Straková K., Wiczkowski W.: Antileukemic action of (-)-epicatechin in the spleen of rats with acute myeloid leukemia. Food Chem Toxicol. 2010; 48: 3391–3397.
10. Papież M.A.: The influence of curcumin and (-)-epicatechin on the genotoxicity and myelosuppression induced by etoposide in bone marrow cells of male rats. Drug Chem Toxicol. 2013; 36: 93–101.
11. Siveen K.S., Uddin S., Mohammad R.M.: Targeting acute myeloid leukemia stem cel signaling by natural products. Mol Cancer. 2017; 16: 1–12.
12. Curry E.A., Murry D.J., Yoder C., Fife K., Armstrong V., Nakshatri H., O’Connell M., Sweeney C.J.: Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer. Invest New Drugs. 2004; 22: 299–305.
13. Knight D.W.: Feverfew: chemistry and biological activity. Nat Prod Rep. 1995; 12: 271–276.
14. Ordóñez P.E., Sharma K.K., Bystrom L.M., Alas M.A., Enriquez R.G., Malagón O., Jones D.E., Guzman M.L., Compadre C.M.: Dehydroleucodine, a Sesquiterpene Lactone from Gynoxys verrucosa, Demonstrates Cytotoxic Activity against Human Leukemia Cells. J Nat Prod. 2016; 79: 691–696.
15. Merfort I.: Perspectives on sesquiterpene lactones in inflammation and cancer. Curr Drug Targets. 2011; 12: 1560–1573.
16. Li C., Jones A.X., Lei X.: Natural product reports synthesis and mode of action of oligomeric sesquiterpene lactones. Nat Prod Rep. 2015; 1–10.
17. Pei S., Minhajuddin M., Callahan K.P., Balys M., Ashton J.M., Neering S.J., Lagadinou E.D., Corbett C., Ye H., Liesveld J.L., O’Dwyer K.M., Li Z., Shi L., Greninger P., Settleman J., Benes C., Hagen F.K., Munger J., Crooks P.A., Becker M.W., Jordan C.T.: Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells. J Biol Chem. 2013; 288: 33542–33558.
18. Klein K., Kaspers G., Harrison C.J., Beverloo H.B., Reedijk A., Bongers M., Cloos J., Pession A., Reinhardt D., Zimmerman M., Creutzig U., Dworzak M., Alonzo T., Johnston D., Hirsch B., Zapotocky M., De Moerloose B., Fynn A., Lee V., Taga T., Tawa A., Auvrignon A., Zeller B., Forestier E., Salgado C., Balwierz W., Popa A., Rubnitz J., Raimondi S., Gibson B.: Clinical impact of additional cytogenetic aberrations, ckit and ras mutations, and treatment elements in pediatric t(8;21)-aml: results from an international retrospective study by the international Berlin–Frankfurt–Münster study group. J Clin Oncol. 2015; 20: 4247–4258.
19. Burnett A.K.: New induction and postinduction strategies in acute myeloid leukemia. Curr Opin Hematol. 2012; 19: 76–81.
20. Kagan V.E., Yalowich J.C., Borisenko G.G., Tyurina Y.Y., Tyurin V.A., Thampatty P., Fabisiak J.P.: Mechanism-based chemopreventive strategies against etoposide-induced acute myeloid leukemia: free radical/antioxidant approach. Mol Pharmacol. 1999; 56: 494–506.
21. Patel N.M., Nozaki S., Shortle N.H., Bhat-Nakshatri P., Newton T.R., Rice S., Gelfanov V., Boswell S.H., Goulet R.J., Sledge G.W., Nakshatri H.: Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by Ikappa-B alpha super-repressor and parthenolide. Oncogene. 2000; 19: 4159–4169.
22. deGraffenried L.A., Chandrasekar B., Friedrichs W.E., Donzis E., Silva J., Hidalgo M., Freeman J.W., Weiss G.R.: NF-kappa B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. Ann Oncol. 2004; 15: 885–890.
23. Tietze F.: Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Ann Biochem. 1969; 27: 502–522.
24. Papież M.A., Krzyściak W., Szade K., Bukowska-Straková K., Kozakowska M., Hajduk K., Bystrowska B., Dulak J., Jozkowicz A.: Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen species. Drug Des Devel Ther. 2016; 10: 557–570.
25. Wurthwein G., Krumpelmann S., Tillmann B., Real E., Schulze-Westhoff P., Jurgens H., Boos J.: Population pharmacokinetic approach to compare oral and i.v. administration of etoposide. Anticancer Drugs. 1999; 10: 807–814.
26. Kim Y.R., Eom J.I., Kim S.J., Jeung H.K., Cheong J.W., Kim J.S., Min Y.H.: Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells. JPET. 2010; 335: 389–400.
27. Vlasova I.I., Feng W., Goff J.P., Giorgianni A., Do D., Gollin S.M., Lewis D.W., Kagan V.E., Yalowich J.C.: Myeloperoxidase-dependent oxidation of etoposide in human myeloid progenitor CD34+ cells. Mol Pharmacol. 2011; 79: 448–479.
28. Seo K.H., Ko H.M., Han A., Kim H.A., Choi J.H., Park S.J., Kim K.J., Lee H.K., Im S.Y.: Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kb activation. Cancer Res. 2006; 66: 4681–4686.
29. Teufelhofer O., Weiss R.M., Parzefall W., Schulte-Hermann R., Micksche M., Berger W., Elbling L.: Promyelocytic HL60 cells express NADPH oxidase and are exellent targets in a rapid spectrophotometric microplate assay for extracellular superoxide. Toxicol Sci. 2003; 76: 376–383.
30. Skalska J., Brookes P.S., Nadtochiy S.M., Hilchey S.P., Jordan C.T., Guzman M.L., Maggirwar S.B., Briehl M.M., Bernstein S.H.: Modulation of cell surface protein free thiols: a potential novel mechanism of action of the sesquiterpene lactone parthenolide. PLoS One. 2009; 2: e8115.
Go to article

Authors and Affiliations

Monika A. Papież
1
Oliwia Siodłak
1
Wirginia Krzyściak
2

  1. Department of Cytobiology, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland
  2. Department of Medical Diagnostic, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

This article summarizes technical aspects of preparing printable 3D anatomical models created from radiological data (CT, MRI) and discusses their usefulness in surgery of the human skull. Interdisciplinary approach to the capabilities of the 3D printers, and the materials used for manufacturing 3D objects oriented on replicating anatomical structures has created new possibilities for simulating and planning surgical procedures in clinical practice settings.
Go to article

Bibliography

1. Ameil M., Delattre J.F., Cordobes B., Flament J.B.: Computerized reconstruction of an anatomical structure based on digitized sections. Anat Clin. 1984; 5 (4): 261–264. doi: 10.1007/BF01798749.
2. Vannier M.W., Marsh J.L., Warren J.O.: Three dimensional CT reconstruction images for craniofacial surgical planning and evaluation. Radiology. 1984; 150 (1): 179–184. doi: 10.1148/radiology.150.1.6689758.
3. Groth C., Kravitz N.D., Jones P.E, Graham J.W., Redmond W.R.: Three-dimensional printing technology. J Clin Orthod. 2014; 48 (8): 475–485. PMID: 25226040.
4. Onuh S.O., Yusuf Y.Y.: Rapid prototyping technology: applications and benefits for rapid product development. J Intell Manuf. 1999; 10 (3–4): 301–311. doi: 10.1023/ A:1008956126775.
5. Anderson J.R., Thompson W.L., Alkattan A.K, Diaz O., Klucznik R., Zhang Y.J., Britz G.W., Grossman R.G., Karmonik C.: Three-dimensional printing of anatomically accurate, patient specific intracranial aneurysm models. J Neurointerv Surg. 2016; 8: 517–520. doi: 10.1136/neurintsurg-2015-011686.
6. Anderl H., Zur Nedden D., Mühlbauer W., Twerdy K., Zanon E., Wicke K., Knapp R.: CT-guided stereolithography as a new tool in craniofacial surgery. Br J Plastic Surg. 1994; 47 (1): 60–64. doi: 10.1016/0007-1226(94)90121-x.
7. Eltorai A.E., Nguyen E., Daniels A.H.: Three-dimensional printing in orthopedic surgery. Orthopedics. 2015; 38 (11): 684–687. doi : 10.3928/01477447-20151016-05.
8. Hoch E., Tovar G.E., Borchers K.: Bioprinting of artificial blood vessels: current approaches towards a demanding goal. Eur J Cardiothorac Surg. 2014; 46 (5): 767– 778. doi: 10.1093/ejcts/ezu242.
9. Kamali P., Dean D., Skoracki R., Koolen P.G., Paul M.A., Ibrahim A.M., Lin S.J.: The current role of three-dimensional printing in plastic surgery. Plast Reconstr Surg. 2016; 137 (3): 1045–1055. doi: 10.1097/01.prs.0000479977.37428.8e.
10. VanKoevering K.K., Hollister S.J., Green G.E.: Advances in 3-dimensional printing in otolaryngology: a review. JAMA Otolaryngol Head Neck Surg. 2017; 143 (2): 178– 183. doi: 10.1001/jamaoto.2016.3002.
11. Pham D.L., Xu C., Prince J.L.: Current methods in medical image segmentation. Annu Rev Biomed Eng. 2000; 2 (1): 315–337. doi: 10.1146/annurev.bioeng.2.1.315.
12. Sharma N., Aggarwal L.M.: Automated medical image segmentation techniques. J Med Phys. 2010; 35 (1): 3–14. doi: 10.4103/0971-6203.58777.
13. Withey D.J., Koles Z.J.: A review of medical image segmentation: methods and available software. Int J Bioelectromagn. 2008; 10 (3): 125–148.
14. Pal N.R., Pal S.K.: A review on image segmentation techniques. Patt Rec. 1993; 26 (9): 1277–1294. doi: 10.1016/0031-3203(93)90135-J.
15. Sahoo P.K., Soltani S.A. Wong A.K.C.: A survey of thresholding techniques. Comput Vis Graph Im Proc. 1988; 41 (2): 233–260. doi: 10.1016/0734-189X(88)90022-9.
16. Winder J., Bibb R.: Medical rapid prototyping technologies: state of the art and current limitations for application in oral and maxillofacial surgery. J Oral Maxillofac Surg. 2005; 63 (7): 1006–1015. doi: 10.1016/j.joms.2005.03.016.
17. Fleiter T., Hoffmann R., Niemeier R., Claussen C.D.: Preoperative planning and follow-up with spiral CT and stereolithographic models in craniofacial surgery. In Advances in CT III. Springer, Berlin, Heidelberg 1994; 149–156.
18. Mankovich N.J., Cheeseman A.M., Stoker N.G.: The display of three-dimensional anatomy with stereolithographic models. J Digit Imaging. 1990; 3 (3): 200–203. doi: 10.1007/BF03167610.
19. Stoker G.N., Mankovich N.J., Valentino D.: Stereolithographic models for surgical planning: preliminary report. J Oral Maxillofac Surg. 1992; 50: 466–471. doi: 10.1016/ s0278-2391(10)80317-9.
20. Eppley B.L., Sadove A.M.: Computer-generated patient models for reconstruction of cranial and facial deformities. J Craniofac Surg. 1998; 9 (6): 548–556. doi: 10.1097/ 00001665-199811000-00011.
21. Müller A., Krishnan K.G., Uhl E., Mast G.: The application of rapid prototyping techniques in cranial reconstruction and preoperative planning in neurosurgery. J Craniofac Surg. 2003; 14 (6): 899–914. doi: 10.1097/00001665-200311000-00014.
22. Singare S., Yaxiong L., Dichen L., Bingheng L., Sanhu H., Gang L.: Fabrication of customised maxillo-facial prosthesis using computer-aided design and rapid prototyping techniques. Rapid Prototyp J. 2006; 12 (4): 206–213. doi: 10.1108/ 13552540610682714.
23. Kermer C., Lindner A., Friede I., Wagner A., Millesi W.: Preoperative stereolithographic model planning for primary reconstruction in craniomaxillofacial trauma surgery. J Craniomaxillofac Surg. 1998; 26 (3): 136–139. doi: 10.1016/s1010-5182(98) 80002-4.
24. Kernan B.T., Wimsatt J.A.: Use of a stereolithography model for accurate, preoperative adaptation of a reconstruction plate. J Oral Maxillofac Surg. 2000; 58 (3): 349– 351. doi: 10.1016/s0278-2391(00)90071-5.
25. Ehrenberg R.: Plastic implant replaces three-quarters of man’s skull. Science News. March 11, 2013.
26. Sunderland I.R., Edwards G., Mainprize J., Antonyshyn O.: A technique for intraoperative creation of patient-specific titanium mesh implants. Plast Surg (Oakv). 2015; 23 (2): 95–99. doi: 10.4172/plastic-surgery.1000909.
27. Bell R.B., Markiewicz M.R.: Computer-assisted planning, stereolithographic modeling, and intraoperative navigation for complex orbital reconstruction: a descriptive study in a preliminary cohort. J Oral Maxillofac Surg. 2009; 67 (12): 2559–2570. doi: 10.1016/j.joms.2009.07.098.
28. D’Urso P.S., Atkinson R.L., Lanigan M.W., Earwaker W.J., Bruce I.J., Holmes A., Barker T.M., Effeney D.J., Thompson R.G.: Stereolithographic (SL) biomodelling in craniofacial surgery. Br J Plast Surg. 1998; 51 (7): 522–530. doi: 10.1054/ bjps.1998.0026.
29. D’Urso P.S., Redmond M.J.: A method for the resection of cranial tumours and skull reconstruction. Br J Neurosurg. 2000; 14 (6): 555–559. doi: 10.1080/ 02688690020005581.
30. Erickson D.M., Chance D., Schmitt S., Mathis J.: An opinion survey of reported benefits from the use of stereolithographic models. J Oral Maxillofac Surg. 1999; 57 (9): 1040–1043.
31. Cui J., Chen L., Guan X., Ye L., Wang H., Liu L.: Surgical planning, three-dimensional model surgery and preshaped implants in treatment of bilateral craniomaxillofacial post-traumatic deformities. J Oral Maxillofac Surg. 2014; 72 (6): 1138-e1-14. doi: 10.1016/j.joms.2014.02.023.
32. Frühwald J., Schicho K.A., Figl M., Benesch T., Watzinger F., Kainberger F.: Accuracy of craniofacial measurements: computed tomography and three-dimensional computed tomography compared with stereolithographic models. J Craniofac Surg. 2008; 19 (1): 22–26. doi: 10.1097/scs.0b013e318052ff1a.
33. Choi J.Y., Choi J.H., Kim N.K., Kim Y., Lee J.K., Kim M.K., Lee J.H., Kim M.J.: Analysis of errors in medical rapid prototyping models. Int J Oral Maxillofac Surg. 2002; 31.(1): 23–32. doi: 10.1054/ijom.2000.0135.
34. Barker T.M., Earwaker W.J., Lisle D.A.: Accuracy of stereolithographic models of human anatomy. Australas Radiol. 1994; 38 (2): 106–111. doi: 10.1111/j.1440-1673.1994.tb00146.x.
35. Chang P.S., Parker T.H., Patrick C.W., Miller M.J.: The accuracy of stereolithography in planning craniofacial bone replacement. J Craniofac Surg. 2003; 14 (2): 164–170. doi: 10.1097/00001665-200303000-00006.
36. Nizam A., Gopal R., Naing N.L., Hakim A.B., Samsudin A.R.: Dimensional accuracy of the skull models produced by rapid prototyping technology using stereolithography apparatus. Arch Orofac Sci. 2006; 1: 60–66.
37. Chia H.N., Wu B.M.: Recent advances in 3D printing of biomaterials. J Biol Eng. 2015; 9 (1): 4. doi: 10.1186/s13036-015-0001-4.
38. Hsieh T.Y., Dedhia R., Cervenka B., Tollefson T.T.: 3D Printing: current use in facial plastic and reconstructive surgery. Curr Opin Otolaryngol Head Neck Surg. 2017; 25 (4): 291–299. doi: 10.1097/MOO.0000000000000373.
39. Jakus A.E., Rutz A.L., Shah R.N.: Advancing the field of 3D biomaterial printing. Biomed Mater. 2016; 11 (1): 014102. doi: 10.1088/1748-6041/11/1/014102.
40. Poukens J., Haex J., Riediger D.: The use of rapid prototyping in the preoperative planning of distraction osteogenesis of the cranio-maxillofacial skeleton. Comput Aided Surg. 2003; 8 (3): 146–154. doi: 10.3109/10929080309146049.
41. Wang Y., Ni M., Tang P.F., Li G.: Novel application of HA-TCP biomaterials in distraction osteogenesis shortened the lengthening time and promoted bone consolidation. J Orthop Res. 2009; 27 (4): 477–482. doi: 10.1002/jor.20782.
42. Ballard D.H., Trace A.P., Ali S., Hodgdon T., Zygmont M.E., DeBenedectis C.M., Smith S.E., Richardson M.L., Patel M.J., Decker S.J., Lenchik L.: Clinical Applications of 3D Printing: Primer for Radiologists. Acad Radiol. 2018; 25 (1): 52–65. doi: 10.1016/j.acra.2017.08.004.
43. Chepelev L., Giannopoulos A., Tang A., Mitsouras D., Rybicki F.J.: Medical 3D printing: methods to standardize terminology and report trends. 3D Print Med. 2017; 3 (1): 4. doi: 10.1186/s41205-017-0012-5.
44. Bauermeister A.J., Zuriarrain A., Newman M.I.: Three-dimensional printing in plastic and reconstructive surgery: a systematic review. Ann Plast Surg. 2016; 77 (5): 569– 576. doi: 10.1097/SAP.0000000000000671.
45. Pham D.L., Xu C., Prince J.L.: Current methods in medical image segmentation. Annu Rev Biomed Eng. 2000; 2 (1): 315–337. doi: 10.1146/annurev.bioeng.2.1.315.
46. Waran V., Devaraj P., Hari Chandran T., Muthusamy K.A., Rathinam A.K., Balakrishnan Y.K., Tung T.S., Raman R., Rahman Z.A.: Three-dimensional anatomical accuracy of cranial models created by rapid prototyping techniques validated using a neuronavigation station. J Clin Neurosci. 2012; 19 (4): 574–577. doi: 10.1016/j.jocn.2011.07.031.
Go to article

Authors and Affiliations

Janusz Skrzat
1

  1. Department of Anatomy, Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

A i m s: Gestational diabetes mellitus (GDM) is an emerging worldwide problem. Changes in clinical characteristics of women affected by GDM in a long-term perspective are still not properly investigated. We aimed to examine such changes over a decade in a retrospective single-center analysis.
M e t h o d s: The medical documentation from Department of Metabolic Diseases, Krakow, Poland was analyzed. We included 633 women consecutively diagnosed with GDM in one of three time intervals: 2007–2008 (N = 157), 2012–2013 (N = 272), 2016–2017 (N = 234). Statistical analyses were performed.
R e s u l t s: Comparison of the three groups identified differences in the mean age of women at the GDM diagnosis (30.7 ± 5.0 years vs. 31.2 ± 4.7 vs. 32.5 ± 4.7, respectively, starting from the earliest 2007–2008 group), pregnancy week at GDM diagnosis (28.0 ± 5.3 wks. vs. 25.9 ± 4.9 vs. 23.4 ± 6.8), the proportion of women diagnosed before the 24th week of pregnancy (12.8% vs. 16.5% vs. 31.3%), and gestational weight gain (12.4 ± 5.0 kg vs. 10.4 ± 5.2 vs. 10.0 ± 5.7); (p = 0.001 or less for all comparisons). We also found differences for glucose values on fasting and at 2 hours with the highest (0 min) and lowest level (120 min) in the 2016–2017, respectively. Finally, a borderline difference for the weight, but not for BMI, was found (64.1 ± 14.1 kg vs. 66.2 ± 13.1 vs. 67.8 ± 15.6; p = 0.04). Differences were also identified in the post hoc analysis between cohorts.
C o n c l u s i o n: This retrospective analysis illustrates changes in characteristics of women with GDM occurring over the period of decade in Poland. They likely result from both epidemiological trends and modifications of the WHO criteria for the GDM diagnosis.
Go to article

Bibliography

1. McIntyre H.D., Catalano P., Zhang C., Desoye G., Mathiesen E.R., Damm P.: Gestational diabetes mellitus. Nat Rev Dis Primers. 2019; 5: 47. JAMA 1967; 200: 1129–1131.
2. Lowe L.P., Metzger B.E., Dyer A.R., et al.: Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care. 2012; 35: 574–580.
3. Gortazar L., Flores-Le Roux J.A., Benaiges D., et al.: Trends in prevalence of gestational diabetes and perinatal outcomes in Catalonia, Spain, 2006 to 2015: the Diagestcat Study. Diabetes Metab Res Rev. 2019; 35: e3151.
4. Cade T.J., Polyakov A., Brennecke S.P.: Implications of the introduction of new criteria for the diagnosis of gestational diabetes: a health outcome and cost of care analysis. BMJ Open. 2019; 9: e023293.
5. Mack L.R., Tomich P.G.: Gestational Diabetes: Diagnosis, Classification and Clinical Care. Obstet. Gynecol. Clin. North Am. 2017; 44: 207–217.
6. Egan A.M., Vellinga A., Harreiter J., et al.: Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia. 2017; 60: 1913– 1921.
7. Lean S.C., Derricott H., Jones R.L., et al.: Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis. PLoS One. 2017; 12: e0186287.
8. Chiefari E., Arcidiacono B., Foti D., et al.: Gestational diabetes mellitus: an updated overview. J Endocrinol Invest. 2017; 40:.899–909.
9. Skupień J., Cyganek K., Małecki M.T.: Diabetic pregnancy: an overview of current guidelines and clinical practice. Curr Opin Obstet Gynecol. 2014; 26: 431–417.
10. Behboudi-Gandevani S., Amiri M., Bidhendi Yarandi R., et al.: The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis. Diabetol Metab Syndr. 2019; 11: 11.
11. HAPO Study Cooperative Research Group, Metzger B.E., Lowe L.P., et al.: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358: 1991–2002.
12. World Health Organization: Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization guideline. Diabetes Res Clin Pract. 2014; 103: 341–363.
13. 2020 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clinical Diabetology, supplement A, 2014.
14. Rybińska A.: Motherhood after the age of 35 in Poland. Studia Demogr. 2014; 1: 7–15.
15. Molina-García L., Hidalgo-Ruiz M., Cocera-Ruíz E.M., et al.: The delay of motherhood: Reasons, determinants, time used to achieve pregnancy, and maternal anxiety level. PLoS One. 2019; 14: e0227063.
16. Matthews T.J., Hamilton B.E.: First births to older women continue to rise. NCHS Data Brief. 2014; 152: 1–8.
17. Hammarberg K., Clarke V.E.: Reasons for delaying childbearing — a survey of women aged over 35 years seeking assisted reproductive technology. Aust Fam Physician. 2005; 34 (3): 187–206.
18. Kim M., Park J., Kim S.H., et al.: The trends and risk factors to predict adverse outcomes in gestational diabetes mellitus: a 10-year experience from 2006 to 2015 in a single tertiary center. Obstet Gynecol Sci. 2018; 61: 309–318.
19. Wender-Ożegowska E., Bomba-Opoń D., Brązert J., et al.: The Polish Society of Gynaecologists and Obstetricians standards for the management of patients with diabetes. Ginekologia i Perinatologia Praktyczna. 2017; 2: 215–229.
20. Egan A.M., Dunne F.P.: Epidemiology of Gestational and Pregestational Diabetes Mellitus. In: Lapolla A., Metzger B.E. (eds.): Gestational Diabetes. A Decade after the HAPO Study. Front Diabetes. Basel, Karger, 2020; 28: 1–10.
21. Egan A.M., Dennedy M.C., Al-Ramli W., et al.: ATLANTIC-DIP: excessive gestational weight gain and pregnancy outcomes in women with gestational or pregestational diabetes mellitus. J Clin Endocrinol Metab. 2014; 99: 212–219.
22. Ferreira L.A.P., Piccinato C.A., Cordioli E., et al.: Pregestational body mass index, weight gain during pregnancy and perinatal outcome: a retrospective descriptive study. Einstein (Sao Paulo). 2019; 18: eAO4851.
23. Brown J., Kapurubandara S., McGee T.M.: Confounding effect of ethnic diversity on booking-in body mass index and prevalence of gestational diabetes and hypertensive disorders in pregnant women in western Sydney 1997–2016. Aust N Z J Obstet Gynaecol. 2020; 60: 369–375.
24. Lavery J.A., Friedman A.M., Keyes K.M., et al.: Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010. BJOG. 2017; 124: 804–813.
25. Fitzpatrick K.E., Tuffnell D., Kurinczuk J.J., et al.: Pregnancy at very advanced maternal age: a UK population-based cohort study. BJOG. 2017; 124: 1097–1106.
Go to article

Authors and Affiliations

Magdalena Wilk
1 2
Katarzyna Cyganek
1 2
Bartłomiej Matejko
1 2
Sabina Krzyżowska
1 2
Izabela Lasoń
1 2
Barbara Katra
1 2
Joanna Zięba-Parkitny
2
Przemysław Witek
1 2
Maciej T. Małecki
1 2

  1. Department of Metabolic Diseases, Jagiellonian University Medical College, Kraków, Poland
  2. University Hospital, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

Background: Due to current increased life expectancy, the quality of life (QoL) of senior patients is gaining in importance. The aims of this study were: to estimate QoL in a group of patients, aged above 64 years, that is cared for by general practitioners (GPs) in Krakow, Poland, and to find relation-ships between elements of QoL and the results of comprehensive geriatric assessment (CGA) and other important medical and social factors.
Methods: We designed a cross-sectional, questionnaire study among patients who attended GPs’ sur-geries from April 2018 to April 2019. To examine the patients, we used the Euro-Quality of Life Ques-tionnaire (EQ-5D-5L) and eight scales forming CGA: the Activities of Daily Living, the Instrumental Activities of Daily Living, Mini-Mental State Examination, Geriatric Depression Scale, Timed Up and Go Test, Mini Nutritional Assessment, Clinical Frailty Scale and Athens Insomnia Scale.
Results: The lowest QoL was observed in dimensions of pain/discomfort and mobility, where 70% and 52% of patients, respectively, reported problems in these areas. Only 91 (21%) respondents had highest results in all five dimensions of QoL. The average score in the Visual Analogue Scale (VAS) of the EQ-5D- 5L (representing self-rated health on a given day) was 62.36 ± 18.98 points. Statistically significant relationships were observed between QoL and age, physical activity and multimorbidity (in all cases p <0.001). The results of QoL were correlated with every aspect of CGA, while the strongest relationship was noticed between scores in the EQ-5D-5L VAS scale and scales assessing depression and frailty (p <0.001; r = –0.57 both).
Conclusions: Our study showed that in senior patients in Krakow QoL was relatively high. Seniors mostly complained of pain/discomfort and problems with mobility. Moreover, dimensions of QoL were connected with the results of CGA. During visits, GPs should specifically question patients about the above mentioned aspects of QoL.
Go to article

Authors and Affiliations

Anna Pachołek
1 2
Eliza Siemaszko-Oniszczuk
3
Joanna Mierzwa
4
Anna Wróbel
5
Karolina Piotrowicz
6
Jerzy Gąsowski
6
Tomasz Tomasik
1 2

  1. Department of Family Medicine, Jagiellonian University Medical College, Kraków, Poland
  2. The College of Family Physicians in Poland
  3. Department of Endocrinology, Diabetology and Internal Diseases, University Clinical Hospital, Białystok, Poland
  4. Second Department of Internal Diseases, Dietl Specialist Hospital, Krakow, Poland
  5. Department of Internal Diseases, City Hospital of Ruda Śląska, Ruda Śląska, Poland
  6. Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

Introduction: Screening sinonasal evaluation is routinely performed before allogeneic hematopoietic cell transplantation (allo-HCT), however, data supporting such evaluation is inconsistent.
Objectives: Assessment of the utility of screening sinonasal evaluation with computed tomography (CT).
Methods: A retrospective analysis of acute leukemia patients who underwent allo-HCT, for whom screening sinonasal CT scans were reevaluated, and for whom Lund-Mackay score (LMS) was calculated.
Results: Forty-eight patients, the median age at allo-HCT 38 years (18–58), 52% males, were included. 79% had acute myeloid leukemia (AML), 21% acute lymphoblastic leukemia (ALL). Conditioning inten-sity was myeloablative in 96% of patients, 21% of patients received total body irradiation. 19% of patients had a history of sinusitis before allo-HCT. Screening sinus CT was performed a median of 22 days before allo-HCT. The median LMS was 1 point (0– 10). The severity of sinus abnormalities was: no abnormalities (31%), mild (67%), moderate (2%), severe (0%). Mucosal thickening was the most frequent abnormality (69%). Eleven patients experienced sinusitis after a median of 93 days (11–607) after allo-HCT. 1-year cumulative incidence of sinusitis was 22%. No threshold of LMS and no type of sinus abnormalities were correlated with sinusitis development after allo-HCT. Mild sinus disease at screening did not negatively impact survival in comparison to no sinus disease.
Conclusions: Despite the fact, that majority of analyzed patients had either no or mild sinus disease at screening a significant proportion of patients developed sinusitis after allo-HCT. Evaluation of LMS before allo-HCT did not help predict the development of sinusitis after the procedure.
Go to article

Authors and Affiliations

Jacek Sokołowski
1
Joanna Drozd-Sokołowska
2
Katarzyna Kobylińska
3
Przemysław Biecek
3
Ewa Karakulska-Prystupiuk
2
Agnieszka Tomaszewska
2
Tomasz Gotlib
1
Kazimierz Niemczyk
1
Wiesław Wiktor-Jędrzejczak
2
Grzegorz Władysław Basak
2

  1. Department of Otolaryngology, Medical University of Warsaw, Warsaw, Poland
  2. Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
  3. Faculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland
Download PDF Download RIS Download Bibtex

Abstract

It was assumed that the temperature at which caffeine is consumed may cause changes in the mechanical and morphological properties of bones and affect the bone metabolism of pregnant female. The aim of the study was to assess the effect of caffeine used at different temperatures on selected morphological and mechanical properties of the femur as well as biochemical indicators of bone formation in female rats in pregnancy. It was use test solution at the temperature 10, 25 and 45ºC from 8 to 21 day during pregnancy, once a day. It was found that the temperature of administrated caffeine may have an effect on changing the morphometric properties and on the bone metabolism of pregnant female rats. The application of caffeine solution, was administrated at 10ºC caused the most constrained growth of the femur and weakened resistance to load, and caused increased susceptibility to cracks. Analysis of bone metabolism indicators showed that caffeine administered in the form of a solution at 10ºC and 25ºC caused the most negativity effects for bone formation and bone turnover indicators. The administration of caffeine at 10ºC causes the largest negative changes in bone morphological and strength indicators and hasn’t a beneficial effect on the bone metabolism of pregnant female rats.
Go to article

Authors and Affiliations

Monika Cendrowska-Pinkosz
1
Wojciech Dworzański
1
Magdalena Krauze
2
Paulius Matuseviĉius
3
Katarzyna Ognik
2
Franciszek Burdan
1

  1. Department of Human Anatomy, Medical University in Lublin, Lublin, Poland
  2. Department of Biochemistry and Toxicology, University of Life Sciences in Lublin, Lublin, Poland
  3. Department of Animal Nutrition, Lithuanian University of Health, Kaunas, Lithuania
Download PDF Download RIS Download Bibtex

Abstract

Undisturbed branched-chain amino acids (BCAA) catabolism is necessary for normal heart function. The key enzyme in BCAA catabolism is a multienzyme branched-chain α-keto acid dehydro-genase complex (BCKDH). BCKDH activity is regulated mainly by reversible dephosphorylation (activa-tion)/phosphorylation (inactivation) cycle catalyzed by regulatory enzymes, a specific phosphatase (PPM1K) and kinase (BDK). 5-fluorouracil (5-FU) is widely used in the treatment of different types of cancer. 5-FU has the potential to cause a wide spectrum of cardiotoxicity, ranging from asymptomatic electrocardiographic changes to cardiomyopathy and subsequent cardiac failure. We hypothesize that 5-FU modifies BCKDH activity and affects cardiac muscle metabolism. The current study was aimed at the investigation of the in vivo effect of 5-FU on BCKDH activity and mRNA levels for E1, PPM1K and BDK. Wistar male rats were administered with 4 doses of 5-FU, 150 mg/kg b.wt. each (study group) or 0.3% methylcellulose (control group). BCKDH activity was assayed spectrophotometrically. The mRNA levels were quantified by real-time PCR. 5-FU treatment caused an increase in BCKDH activity that appears to result mainly from increased dephosphorylation of the complex and is associated with an increase of PPM1K mRNA level and reduction of BDK and E1 mRNA levels. It is conceivable that 5-FU stimulation of BCKDH is an adaptive reaction with the purpose of enhancing the BCAA catabolism and protecting from toxic effect caused by excessive accumulation of these amino acids in heart.
Go to article

Authors and Affiliations

Małgorzata Knapik-Czajka
1
Michał Jurczyk
2
Justyna Bieleń
1
Veronika Aleksandrovych
2
Anna Gawędzka
1
Paulina Stach
2
Jagoda Drąg
1
Krzysztof Gil
3

  1. Department of Biochemical Analytics, Jagiellonian University Medical College, Kraków, Poland
  2. Department of Pathophysiology, Jagiellonian University Medical College, Kraków, Poland
  3. 2Department of Pathophysiology, Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

O b j e c t i v e s: Periapical inflammation is one of the most common pathologies within the jaws, leading to the destruction of periodontal ligaments, bone resorption and the formation of periapical granulomas or radicular cysts. The final diagnosis can be made only on the basis of histopathological examination. The aim of the study was to assess the conformity between clinical and histopathological diagnosis of inflammatory periapical lesions treated with apicoectomy.
M a t e r i a l s a n d M e t h o d s: The case histories of 52 patients subjected to surgical treatment at the Clinic of Conservative Dentistry with Endodontics between 2008 and 2018 were analyzed. Demographic data (age, gender), clinical (radiological) diagnosis, and data on the presence of sinus tracts and causal tooth were obtained from patients’ records. R e s u l t s: In the light of clinical and radiological examination, 32 (61.5%) periapical granulomas, 18 (34.6%) radicular cysts and 2 (3.9%) periapical scars were diagnosed, whereas the result of histopathological examination revealed granuloma in 34 (65.4%) cases and in 18 (34.6%) — radicular cyst. For clinical diagnosis of granuloma, the result coincided with the result of the histopathological examination in 28 cases, and in the case of cysts in 14. The analysis showed a significant relationship between the clinical and histopathological diagnoses (p <0.05).
C o n c l u s i o n s: The study emphasizes the importance of histopathological assessment for the proper diagnosis of periapical lesions.
C l i n i c a l R e l e v a n c e: The article emphasizes the high importance of histopathological examination for the correct diagnosis of chronic inflammatory periapical lesions.
Go to article

Bibliography

1. Nair P.N.R.: Pathogenesis of apical periodontitis and the cause of endododontic failures. Crit Rev Oral Biol Med. 2004; 15 (6): 348–381.
2. Dominiak M., Łysiak K., Znamirowska A., Szczepański W., Hałoń A.: Porównanie zgodności oceny klinicznej, histopatologicznej oraz radiologicznej przewlekłych zmian okołowierzchołkowych. Dent Med Probl. 2006; 43 (4): 504–510.
3. White E.: Podstawy radiodiagnostyki stomatologicznej. Wydawnictwo Medyczne Sanmedica, Warszawa, 1994; pp. 242–244.
4. Tay J.Y.Y., Bay B.H., Yeo J.F., Harris M., Meghji S., Dheen S.T.: Identification of RANKL in osteolytic lesions of the facial skeleton. J Dent Res. 2004; 83 (4): 349–353.
5. Ratajczak M., Sowa W., Walter A.: Molekularne podstawy powstawania zębopochodnej torbieli zapalnej — przegląd piśmiennictwa. Dent Med Probl. 2010; 47 (4): 496–501.
6. Garcia C.C., Sempere F.V., Diago A.P., Bowen E.M.: The post-endodontic periapical lesion: Histologic and etiopathogenic aspects. Med Oral Patol Oral Cir Bucal. 2007; 12 (8): 585–590.
7. Nair P.N.R., Sundqvist G., Sjögren U.: Experimental evidence supports the abscess theory of development of radicular cysts. Oral Surgery, Oral Med Oral Pathol Oral Radiol Endodontology. 2008; 106 (2): 294–303.
8. Von Arx T.: Apical surgery: A review of current techniques and outcome. Saudi Dent J. 2011; 23 (1): 9–15.
9. Diegues L.L., Robazza C.R.C., Hanemann J.A.C., Pereira A.A.C., Silva C.O.: Correlation between clinical and histopathological diagnoses in periapical inflammatory lesions. J Investig Clin Dent. 2011; 2 (3): 184–186.
10. Love R.M., Firth N.: Histopathological profile of surgically removed persistent periapical radiolucent lesions of endodontic origin. Int Endod J. 2009; 42 (3): 198–202.
11. Akinyamoju A.O., Gbadebo S.O., Adeyemi B.F.: Periapical lesions of the jaws: a review of 104 cases in ibadan. Ann Ibd Pg Med. 2014; 12 (2): 115–119.
12. Lin H.P., Chen H.M., Yu C.H., Kuo R.C., Kuo Y.S., Wang Y.P.: Clinicopathological study of 252 jaw bone periapical lesions from a private pathology laboratory. J Formos Med Assoc. 2010; 109 (11): 810–818.
13. Carrillo C., Penarrocha M., Ortega B., Martí E., Bagán J.V., Vera F.: Correlation of Radiographic Size and the Presence of Radiopaque Lamina With Histological Findings in 70 Periapical Lesions. J Oral Maxillofac Surg. 2008; 66 (8): 1600–1605.
14. Obuchowicz R., Nurzyńska K., Obuchowicz B., Urbanik A., Piórkowski A.: Use of Texture Feature Maps for the Refinement of Information Derived from Digital Intraoral Radiographs of Lytic and Sclerotic Lesions. Appl Sci. 2019; 9 (15): 2968.
Go to article

Authors and Affiliations

Paweł Myciński
1
Katarzyna Dobroś
1
Tomasz Kaczmarzyk
2
Joanna Zarzecka
1

  1. Department of Conservative Dentistry with Endodontics, Institute of Dentistry, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
  2. Department of Oral Surgery, Institute of Dentistry, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

Temporomandibular disorders (TMD) encompass a diverse group of abnormalities in the functioning of the masticatory muscles, temporomandibular joints, and surrounding structures within the facial skull. One of the important etiological factors, contributing to the development of TMD are psychoemotional disorders, which include: depression, dysthymia, personality disorders, panic attacks as well as states and anxiety neuroses.
The aim of the study was to carry out a retrospective evaluation of the occurrence of psychoemotional disorders reported in the application form of medical interview of patients treated at the Consulting Room of Temporomandibular Disorders in Dental Institute (University Dental Clinic) for TMD.
The research material consisted of a subjective survey according to the protocol of the RDC/TMD questionnaire, axis II, of the 360 patients (224 women, 136 men), aged 19 to 43 who came to the University Dental Clinic in Krakow due to TMD management.
Result: The results of the conducted studies indicate the common occurrence of emotional disorders in the group of patients treated for TMD, both in the group of muscular and joint form of dysfunctions. The most often the patients selected: loss of sexual interest or pleasure, crying easily, feeling lonely, indifference to every-thing and feeling of worthlessness. These aspects show a significant influence of emotional factors on TMD.
Conclusion: The results of the conducted research indicate a significant frequencies of psychological and emotional disturbances reported in a survey among patients with TMD. Key
Go to article

Authors and Affiliations

Małgorzata Pihut
1
Magdalena Krasińska-Mazur
1
Joanna Biegańska-Banaś
2
Andrzej Gala
1

  1. Consulting Room of Temporomandibular, Disorders, Dental Institute, Prosthodontics Department, Jagiellonian University Medical College, Kraków, Poland
  2. Institute of Nursing and Midwifery, Department of Health Psychology, Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

Isolated internal iliac artery aneurysms are rarely described in the available literature. The paper presents a case of a 70-year-old female with idiopathic thrombocytopenia, squamous cell cervical carci-noma, and saccular aneurysm of the left internal iliac artery, detected in magnetic resonance. The review of aneurysm of the common, external and internal iliac arteries is added.
Go to article

Authors and Affiliations

Franciszek Burdan
1 2
Krzysztof Czarnocki
1
ORCID: ORCID
Agnieszka Mocarska
1
Maciej Burdan
2
Iwonna Żelazowska-Cieślińska
1
Elżbieta Starosławska
1

  1. St. John’s Cancer Centre, Lublin, Poland
  2. Human Anatomy Department, Medical University of Lublin, Lublin, Poland
Download PDF Download RIS Download Bibtex

Abstract

Intensive hypoglycemic treatment is the strongest preventive strategy against the development of microvascular complications of type 2 diabetes (T2DM), including diabetic nephropathy. However, some antidiabetic drugs, i.e. sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP1-RA) have an additional renoprotective effect beyond glucose control by itself. Similar, both SGLT-2i and GLP1-RA have been demonstrated to decrease the risk of adverse cardiovascular (CV) events in CV outcome trials. Nevertheless, there are relevant differences in CV and renal effects of SGLT-2i and GLP1-RA. First, SGLT2i reduced the incidence and progression of albuminuria and prevented loss of kidney function, while predominant renal benefits of GLP1-RA were driven by albuminuria outcomes. Second, the risk of heart failure (HF) hospitalizations decreased on SGLT2i but not on GLP1-RA, which gives priority to SGLT2i in T2DM and HF, especially with depressed EF. Third, either GLP1-RA (reducing predominantly atherosclerosis-dependent events) or SGLT-2i, should be used in T2DM and established atherosclerotic CV disease (ASCVD) or other indicators of high CV risk. In this review, we have briefly compared clinical practice guidelines of the American Diabetes Association (2020 and 2021 versions), Polish Diabetes Association (2020) and the European Society of Cardiology/European Association for the Study of Diabetes (2019), with a focus on the choice between SGLT-2i and GLP1-RA in patients with diabetic kidney disease.
Go to article

Bibliography

1. American Diabetes Association: Microvascular complications and foot care: Standards of Medical Care in Diabetes-2021. Standards of Medical Care in Diabetes–2020. Diabetes Care. 2020; 43 (Suppl 1): S135–S151.
2. American Diabetes Association: Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020; 43 (Suppl 1): S98–S110.
3. American Diabetes Association: Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021; 44 (Suppl 1): S111–S124.
4. Williams D.M., Nawaz A., Evans M.: Renal outcomes in type 2 diabetes: A review of cardiovascular and renal outcome trials. Diabetes Ther. 2020; 11: 369–386.
5. Heerspink H.J.L., Stefánsson, B.V., Correa-Rotter, et al.: Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020; 383: 1436–1446.
6. Jhund P.S., Solomon S.D., Docherty K.F., et al.: Efficacy of dapagliflozin on renal function and outcomes in patients with heart failure with reduced ejection fraction: Results of DAPA-HF. Circulation 2020 Oct 12; doi: 10.1161/CIRCULATIONAHA.120.050391.
7. Packer M., Anker S.D., Butler J., et al.: Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020; 383: 1413–1424.
8. American Diabetes Association: Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019; 42 (Suppl 1): S90–S102.
9. Diabetes Poland (Polish Diabetes Association): 2020 Guidelines on the management of diabetic patients: A position of Diabetes Poland. Clin Diabetol. 2020; 9: 1–101.
10. Cosentino F., Grant P.J., Aboyans V., et al.: 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020; 41: 255–323.
Go to article

Authors and Affiliations

Ewa Wieczorek-Surdacka
1
Andrzej Surdacki
2
Jolanta Świerszcz
3
Bernadeta Chyrchel
4

  1. Chair and Department of Nephrology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
  2. Second Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland
  3. Department of Medical Education, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
  4. Second Department of Cardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

Introduction: The Dundee Ready Education Environment Measure (DREEM) is an instru-ment that assesses the educational environment.
Aim: The aim of this study was to psychometrically evaluate a Polish version of the DREEM instrument.
Material and Methods: 203 medical students who fully completed the DREEM questionnaire were included in the study. Validity was evaluated through the analysis of construct validity and reliability.
Results: After language validation the internal consistency was assessed. Cronbach’s alpha for the overall score was 0.93 and the five subscales were: perceptions of learning 0.86, perceptions of teachers 0.82, perceptions of atmosphere 0.75, academic self-perceptions 0.61, and social-self perceptions 0.61. The exploratory factor analyses, however, yielded dimensions that did not fully correspond to the original DREEM subscales.
Conclusions: Internal consistency of the Polish version of the DREEM scale as a whole was excellent, however for each of five originally developed subscales it was lower and vary a lot; construct validity of Polish version was not compatible with the original structure of the DREEM scale but was reasonable. A new five-factor solution obtained in this study could be a reliable tool for assessing the medical education environment in the Polish circumstances, but it will require confirmation in future study.
Go to article

Authors and Affiliations

Dorota Zawiślak
1
Kamila Żur-Wyrozumska
1
Mariusz Habera
1
Karolina Skrzypiec
1
Agnieszka Pac
2
Grzegorz Cebula
1

  1. Department of Medical Education, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
  2. Chair of Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

The SARS-CoV-2 pandemic contributed to the implementation of changes in the methodology of conducting many courses at medical universities. Achieving learning outcomes was associated with self-discipline and an increased portion of students’ independent work. The aim of the study is to analyze the adaptation of teaching methods to the requirements of the COVID-19 pandemic at the Department of Medical Education of Jagiellonian University Medical College. The university authorities, instructors and students made every effort not to neglect their education. The Microsoft Teams platform allowed for the efficient organization of remote classes. Lectures, activities based on dialogue, brainstorming and role- -playing were conducted via the Internet. Presentations and short films were made available to students. The safety of individuals participating in classes was guaranteed by password access and an invitation sent prior to an online meeting. Remote learning allowed for the synthesis and deepening of students’ knowledge, improvement of communication skills and development of clinical thinking as future doctors. The disadvantages of online education was the inability to improve practical skills, especially on phantoms, under the direct supervision of a trained instructor.
Go to article

Bibliography

1. Ahmad Al Samaraee: The impact of the COVID-19 pandemic on medical education. British Journal of Hospital Medicine. 2020; 81 (7). Published Online: 20 Jul 2020 https://doi.org/10.12968/ hmed.2020.0191.
2. Skrzypek A., Stalmach-Przygoda A., Dębicka-Dąbrowska D., Kocurek A., Szopa M., Górski S., Szeliga M., Małecki M., Grodecka A., Cebula G., Nowakowski M.: Selected didactic methods used in education of medical students at the Department of Medical Education of Jagiellonian University Medical College. What’s new in medical didactics? General and Professional Education. 2018; 1: 26–32.
3. Silverman J., Kurtz S., Draper J.: Skills for Communicating with Patients, 3rd edition. London: CRC Press, 2016.
4. Małecki Ł., Stalmach-Przygoda A., Górski S., Kocurek A., Skrzypek A., Kowalska B., Nowakowski M.: Wprowadzenie całościowego kursu komunikacji medycznej dla studentów Wydziału Lekarskiego Uniwersytetu Jagiellońskiego Collegium Medicum.= The introduction of a comprehensive communication course for medical students of the Faculty of Medicine at the Jagiellonian University Medical College. Uniwersytet Jagielloński Collegium Medicum Zakład Dydaktyki Medycznej. Sztuka Leczenia. 2017; 1: 73–84.
5. Maran N.J., Glavin R.J.: Low- to high-fidelity simulation — a continuum of medical education? Medical Education. 2003; 37: 22–28.
6. Nikendei Ch., Huber J., Stiepak J., Huhn D., Lauter J., Krautter M.: Modification of Peyton’s four-step approach for small group teaching — a descriptive study. BMC Medical Education. 2014. https://doi. org/10.1186/1472-6920-14-68.
7. Skrzypek A., Szeliga M., Jagielski P., Perera I., Dębicka-Dąbrowska D., Wilczyńska-Golonka M., Górecki T., Cebula G.: The modified Peyton approach in the teaching of cardiac auscultation. Folia Med Crac. 2019; 59 (4): 21–32.
8. Skrzypek A., Kocurek A., Stalmach-Przygoda A., Małecki Ł., Górski S., Kowalska B., Szeliga M., Jabłoński K., Matłok M., Cebula G., Nowakowski M.: Rola profesjonalnych pacjentów symulowanych w nauczaniu komunikacji klinicznej. The role of professional simulated patients in teaching of clinical communication. General and Professional Education. 2017; 4: 29–35.
9. Czekajlo M., Dabrowski M., Dabrowska A.: Symulacja medyczna jako profesjonalne narzędzie wpływające na bezpieczeństwo pacjenta wykorzystywane w procesie nauczania. Merkur Lekarski. 2015; 38 (228): 360–363.
10. Green M., Tariq R., Green P.: Improving Patient Safety through Simulation Training in Anesthesiology: Where Are We? Anesthesiol Res Pract. 2016; 4237523. doi: 10.1155/2016/4237523. Epub 2016 Feb 1.
11. Dieckmann P., Patterson M., Lahlou S., Mesman J., Nystrom P., Krage R.: Variation and adaptation: learning from success in patient safety-oriented simulation training. Adv Simul (Lond). 2017; 2: 21. doi: 10.1186/s41077-017-0054-1.
12. Skrzypek A., Cegielny T., Szeliga M., Jabłoński K., Nowakowski M.: Different perceptions of Problem Based Learning among Polish and Scandinavian students. Is PBL the same for everyone? Preliminary study. General and Professional Education. 2017; 3: 58–64.
13. McMillan M., Little P.: Conceptualizing Problem-Based Learning: Ensuring Realization of Curriculum Intentions. J Probl Based Learn. 2020; 7 (1):1–2.
14. Lucey C.R., Johnston S.C.: The Transformational Effects of COVID-19 on Medical Education. JAMA. 2020; 324 (11): 1033–1034. doi: 10.1001/jama.2020.14136.
Go to article

Authors and Affiliations

Agnieszka Skrzypek
1
Ian Perera
1
Marta Szeliga
1
Grzegorz Cebula
1

  1. Department of Medical Education, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
Download PDF Download RIS Download Bibtex

Abstract

Background/Aim: Factors influencing the survival of the nursing home population have not yet been clearly defined. The aim of the study was to investigate the impact of nutritional, mental, functional, disease and pharmacological factors on the survival of nursing home residents with severe disabilities.
Material and Methods: A retrospective cohort study was conducted with a 9-year follow-up period among nursing home residents with a Barthel score ≤40. The initial assessment included the following scales: Mini Nutritional Assessment Short-Form (MNA-SF), Abbreviated Mental Test Score (AMTS), the Barthel Index, and blood pressure (BP) measurements. Comorbidities, medications and all-cause mortality were extracted from medical records. The analyzed cohort was divided into two groups: Deceased — residents who died ≤3 years and Survivors — those who survived >3 years of observation.
Results: Survivors (n = 40) and Deceased (n = 48) did not differ significantly in terms of age, sex, systolic and diastolic BP, the Barthel Index, number of diseases and medications used. Survivors had significantly higher scores in MNA-SF (p <0.001) and AMTS (p <0.003) than Deceased. Moreover, Survivors had hyper-tension significantly more often and took aspirin and ACE inhibitors (p <0.05). The multivariable logistic regression analysis showed that the MNA-SF score significantly affected mortality [OR = 0.62, (95%CI, 0.46– 0.84), p <0.001].
Conclusion: Higher MNA-SF scores were a factor that significantly affected the survival of nursing home residents, while functional status assessed using the Barthel Index had no effect on survival. MNA-SF was found to be a useful tool for assessing the risk of death in a nursing home.
Go to article

Authors and Affiliations

Anna Kańtoch
1
Jadwiga Wójkowska-Mach
2
Barbara Wizner
1
Piotr Heczko
2
Tomasz Grodzicki
1
Barbara Gryglewska
1

  1. Department of Internal Medicine and Gerontology, Faculty of Medicine, Jagiellonian University Medical College, University Hospital in Kraków, Kraków, Poland
  2. Department of Microbiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland

This page uses 'cookies'. Learn more